Brind.
  1. Veracyte, a company headquartered in San Francisco, CA, offers diagnostic tests through central laboratories in the United States.

Medicare Now Covers Veracyte Diagnostic Tests

1 report, 1 independent Updated Sun 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Veracyte, a cancer diagnostics company, secured reimbursement from Medicare for its diagnostic tests. The company recently reported third-quarter financial results for the period ended September 30, 2026. During that quarter, total revenue increased by 15% to $151.8 million, and testing revenue grew 15% to $146.4 million.

From manilatimes.net

Why it matters

Some supportBrind's analysis of the reports

The inclusion of Veracyte's tests under Medicare coverage could create a new revenue stream for hospitals that perform the tests. This decision also expands covered services and revenue streams for CMS.

Veracyte, headquartered in San Francisco, CA, offers diagnostic tests through central laboratories in the United States.

From manilatimes.net

Who's involved

  • MedicareUS federal health insurance that now covers the diagnostic tests
  • CMSImplements the reimbursement decision for covered services
  • hospitalHealth care facility that might perform the covered tests

Who could feel it

Possible knock-on effects

These are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.

  • hospitalSpeculative

    Hospitals might see increased revenue from performing the diagnostic tests covered by Medicare.

  • CMSSpeculative

    CMS could expand its covered services and revenue streams due to the reimbursement decision.

Keep exploring

Part of

Veracyte, a company headquartered in San Francisco, CA, offers diagnostic tests through central laboratories in the United States.

Also in this story

All 3 developments

The entities involved

Coverage

Newest first; wire copies grouped